Cellular & Molecular Medicine: Open access

Differences Between Normal and Malignant Tissues of Stomach Cancer On a Molecular Level

It would be critical in the research of stomach cancer to be able to define the distinctions between normal and malignant tissues at a molecular level. Expression profiling of 86 tissues on 17K complementary DNA microarrays was used to study the gene expression pattern in the two kinds of gastric cancer tissues. A class classification technique was used to find differentially expressed genes. To choose predictors, samples were separated into two groups: training (n = 58) and test (n = 28). A t-test was utilised to pick a group of 894 genes in a training set, which were then used for cross-validation and class (normal or tumour) prediction in the test set. PBDs are a complex set of autosomal recessive illnesses that are divided into two clinically different subtypes: the Zellweger syndrome spectrum (ZSS) disorders and rhizomelic chondrodysplasia punctata (RCDP) type 1. Defects in any of at least 14 distinct PEX genes, which encode proteins involved in peroxisome formation and proliferation, are the cause of PBDs. Real-time RT-PCR may be used to confirm the expression ratios of the 5 genes picked from microarray data over 6 tissue samples, resulting in a high level of correlation, either alone or in combination. When a representative predictor set of 92 genes was examined, the pathways of 'focal adhesion' (with gene components of THBS2, PDGFD, MAPK1, COL1A2, COL6A3), 'ECM-receptor interaction' (THBS2, COL1A2, COL6A3, FN1), and 'TGFbeta signalling' (THBS2, MAPK1, INHBA) represented some of the major molecular differences.

Author(s): Douglas Vessy*

Abstract | PDF

Share this